Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.
Read More…
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
Phone+972-7-32442200
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Syneron Medical (NASDAQ:ELOS) Frequently Asked Questions
What is Syneron Medical's stock symbol?
Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."
How were Syneron Medical's earnings last quarter?
Syneron Medical Ltd. (NASDAQ:ELOS) announced its quarterly earnings data on Thursday, August, 4th. The medical equipment provider reported $0.09 EPS for the quarter, beating the Zacks' consensus estimate of $0.06 by $0.03. The medical equipment provider had revenue of $75 million for the quarter, compared to analyst estimates of $75.72 million. The firm's quarterly revenue was up 2.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.07 EPS. View Syneron Medical's Earnings History.
Has Syneron Medical been receiving favorable news coverage?
News stories about ELOS stock have trended very negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Syneron Medical earned a news impact score of -3.2 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Syneron Medical.
What other stocks do shareholders of Syneron Medical own?
Who are Syneron Medical's key executives?
Syneron Medical's management team includes the folowing people:
- Shimon Eckhouse Ph.D., Chairman of the Board
- Amit Meridor, Chief Executive Officer
- , Bio & Compensation -
- Hugo Goldman, Chief Financial Officer
- , Bio & Compensation -
- Erik Dowell, Vice President-North America
- William Griffing, Chief Executive Officer - Syneron Candela North America
- Shlomo Alkalay, Chief Operating Officer
- Lisa A. Soderquist, Chief Human Resource Officer
- , Bio & Compensation -
- Robert Ruck, Executive Vice President, Asia Pacific
- Robert Fielitz, Vice President and Managing Director of Europe, Middle East and Africa
- Sarit Soccary Ben-Yochanan, Vice President - Business Development & Strategy
What is Syneron Medical's official website?
How can I contact Syneron Medical?
Syneron Medical's mailing address is Tavor Building 4 P.O. Box 550, YOKNEAM, 2069200, Israel. The medical equipment provider can be reached via phone at +972-7-32442200.
MarketBeat Community Rating for Syneron Medical (NASDAQ ELOS)
MarketBeat's community ratings are surveys of what our community members think about Syneron Medical and other stocks. Vote "Outperform" if you believe ELOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELOS will underperform the S&P 500 over the long term. You may vote once every thirty days.
